VX-548

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for VX-548, covering 2024-04-29 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR) [Phase 2]